Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBI-1 in Congenital Hemophilia A with Inhibitors
NCT00245245Phase 2Completed
- Sponsor
- Octagen
- Start
- May 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of susoctocog alfa in hemophilia A, sponsored by Octagen. Started May 2005; status: completed.
02
Drugs
susoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00245245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245245.